Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ESPR > SEC Filings for ESPR > Form 8-K on 19-May-2014All Recent SEC Filings

Show all filings for ESPERION THERAPEUTICS, INC.

Form 8-K for ESPERION THERAPEUTICS, INC.


19-May-2014

Submission of Matters to a Vote of Security Holders


Item 5.07. Submission of Matters to a Vote of Security Holders.

Esperion Therapeutics, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting") on May 15, 2014. As of April 1, 2014, the record date for the Annual Meeting, there were 15,394,226 outstanding shares of the Company's common stock. The Company's stockholders voted on the following matters, which are described in detail in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission ("SEC") on April 4, 2014: (i) to elect Daniel Janney, Tim M. Mayleben, and Mark E. McGovern, M.D. as Class I directors of the Company to each serve for a three-year term expiring at the Company's annual meeting of stockholders in 2017 and until their successors have been elected and qualified ("Proposal 1"),
(ii) to ratify the Company's 2013 Stock Option and Incentive Plan ("Proposal 2"), and (iii) to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014 ("Proposal 3").

The Company's stockholders approved the Class I director nominees recommended for election in Proposal 1 at the Annual Meeting. The Company's stockholders voted for Class I directors as follows:

Class I Director Nominee      For       Against   Abstain   Broker Non-Votes
Daniel Janney              11,147,650   251,392     2,479          2,727,627
Tim M. Mayleben            11,392,337     6,705     2,479          2,727,627
Mark E. McGovern, M.D.     11,393,842     5,200     2,479          2,727,627

The Company's stockholders approved Proposal 2. The votes cast at the Annual Meeting were as follows:

For Against Abstain Broker Non-Votes 9,589,682 1,800,950 10,889 2,727,627

The Company's stockholders approved Proposal 3. The votes cast at the Annual Meeting were as follows:

For Against Abstain
14,114,480 3,300 11,368

No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting.

* * *


  Add ESPR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ESPR - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.